Clinical investigation of medicinal products indicated for generalised anxiety disorder

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCPMP/EWP/4284/2002
Published20/01/2005
Effective from01/07/2005
KeywordsAnxiety, general anxiety disorder (GAD)
DescriptionThis document provides guidance on the evaluation of new medicinal products intended for the use in the treatment of generalised anxiety disorder.


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more